TY - JOUR T1 - Cardiovascular benefits of HRT may differ by patient age JF - Evidence Based Medicine JO - Evid Based Med SP - 61 LP - 61 DO - 10.1136/eb-2013-101430 VL - 19 IS - 2 AU - Giuseppe Rosano AU - Cristiana Vitale Y1 - 2014/04/01 UR - http://ebm.bmj.com/content/19/2/61.abstract N2 - Commentary on: Main C, Knight B, Moxham T, et al. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Cochrane Database Syst Rev 2013;(4):CD002229. In early postmenopausal women oestrogen and/or hormone replacement therapy (ERT/HRT) are used to alleviate symptoms and reduce the probability of diseases related to ovarian hormones deprivation. However, in late postmenopausal women the initiation of HRT has a negative risk/benefit balance mainly because of the increased risk of cardiovascular diseases (CVD). Main et al performed a meta-analysis of randomised controlled trials (RCTs) comparing oral ERT/HRT with either a placebo or a no-treatment control for 6 months or longer. Included in the analysis were those women with the evidence of being menopausal either with or without evidence of existing CVD. Two authors assessed study quality and extracted data from those references … ER -